Keros Therapeutics (KROS) Share-based Compensation (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Share-based Compensation (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -303.76% |
| Jun 30, 2025 | -3.62% |
| Mar 31, 2025 | -3.66% |
| Dec 31, 2024 | 4.34% |
| Sep 30, 2024 | 0.36% |
| Jun 30, 2024 | 8.86% |
| Sep 30, 2023 | -200.00% |
| Jun 30, 2023 | 751.27% |
| Mar 31, 2023 | -91.32% |
| Dec 31, 2021 | 6.84% |
| Sep 30, 2021 | 8.25% |
| Jun 30, 2021 | 14.23% |
| Mar 31, 2021 | -38.47% |
| Dec 31, 2020 | 466.12% |
| Sep 30, 2020 | -197.19% |
| Jun 30, 2020 | 9,391.67% |
| Mar 31, 2020 | -33.33% |
| Dec 31, 2019 | 5.88% |
| Sep 30, 2019 | 30.77% |
| Jun 30, 2019 | 18.18% |